Generic Drug Settlement: Submit Your Claim Today

This settlement resolves claims that generic drug manufacturers conspired to inflate the prices of dozens of generic drugs, violating federal and state antitrust laws. The settlement provides compensation to End-Payer Plaintiffs (EPPs)—including union benefit funds, self-funded employers, municipalities, and others—that paid for or reimbursed these drugs from May 1, 2009 to December 31, 2019.

The court has preliminarily approved a $275 million settlement with Sandoz and Fougera Pharmaceuticals, with additional settlements expected.‍‍

Entities are eligible to participate in the End-Payer Settlement if they operated in:
✅ Any of the 48 U.S. states (excluding Indiana and Ohio)
✅ The District of Columbia
✅ Puerto Rico
✅ The U.S. Virgin Islands

The only states that are not eligible are:
✅ Indiana
✅ Ohio

If your organization operated in any of the included regions and paid for or reimbursed the cost of the eligible generic drugs, you may qualify to file a claim.

To complete your claim, please gather:

✅ Tax ID (TIN/EIN) and contact information
✅ Type of plan or entity (self-funded, union, etc.)
✅ National Drug Codes (NDCs) or drug names
✅ Transaction-level data showing dates of service, amounts paid, and units (2009–2019)
✅ Source of your data (PBM, TPA, in-house, etc.)
‍
Helpful formats: Excel spreadsheets, CSVs, PDF summaries from PBMs or administrators

Steps:

1️⃣ Review eligibility; contact VMC Group with any questions
2️⃣ Sign the Generics Service Agreement
3️⃣ Receive claims worksheet from VMC
4️⃣ Upload your documents
5️⃣ Submit

Our team is here to assist with data prep or filing questions.